eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/10/2011
PIL FOSAVANCE Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
Updated on 19/07/2011 and displayed until 21/10/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to side-effects
Updated on 05/04/2011 and displayed until 19/07/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 13/01/2011 and displayed until 05/04/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 21/05/2010 and displayed until 13/01/2011
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 26/11/2009 and displayed until 21/05/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 24/07/2009 and displayed until 26/11/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to dosage and administration
Updated on 27/04/2009 and displayed until 24/07/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 15/01/2009 and displayed until 27/04/2009
Reasons for adding or updating:
  • Change to Further Information section
Updated on 19/09/2008 and displayed until 15/01/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 04/08/2008 and displayed until 19/09/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 27/05/2008 and displayed until 04/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 24/01/2008 and displayed until 27/05/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 18/01/2007 and displayed until 24/01/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 01/09/2005 and displayed until 18/01/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  colecalciferol
  alendronate sodium trihydrate